Contact FreedomWorks

400 North Capitol Street, NW
Suite 765
Washington, DC 20001

  • Toll Free 1.888.564.6273
  • Local 202.783.3870

All the Latest

    Everything
  • Blog
  • Events
  • Press
  • Key Votes
  • Podcasts
  • Videos
  • Tweets
  • Photos

About

Problems With More Regulation in the Credit Markets...
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Blog

Problems With More Regulation in the Credit Markets...

Democrats such as House Financial Services Chairman Barney Frank and Senate Banking Committee Chairman Christopher Dodd have continued to press for what they consider to be necessary financial reform.

03/11/2010
Democratic Support for EPA Regulation of Emissions Is Declining...
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Blog

Democratic Support for EPA Regulation of Emissions Is Declining...

Slowly but surely, Democratic support for the EPA’s regulation of greenhouse gases is waning.  Recently, West Virginia Democratic Sen. John Rockefeller introduced legislation that would prohibit the EPA from going forward with its regulation scheme for the next two years. Sen. Rockefeller, a coal state Democrat, contends that protecting jobs is vital, and that that is precisely what his EPA proof legislation intends to do. Politico reports that Sen.

03/09/2010
Key Vote "No": Wall Street Act H.R. 4173
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Press Release

Key Vote "No": Wall Street Act H.R. 4173

[To view the pdf version of this letter click here]

12/11/2009
Federal Reserve Transparency Working Group Sends Letter to the Senate
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Press Release

Federal Reserve Transparency Working Group Sends Letter to the Senate

Dear Members of the U.S. Senate: In the last two years, the Federal Reserve Board has lent several trillion dollars to banks and other private companies, financial and non-financial institutions through a series of special lending facilities. The total amount of loans made through facilities exceeds the annual budget of the United States. In addition, it guaranteed trillions of dollars of various assets and also made hundreds of billions of dollars available to several foreign central banks through currency swap arrangements. 

12/03/2009
Obama Justice Department: Voters Just Don't Know What's Good for Them
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Blog

Obama Justice Department: Voters Just Don't Know What's Good for Them

In a display of arrogance and racial politics shocking even for this administration, President Obama's Justice Department recently invalidated the will of an overwhelming majority of voters in Kinston, NC to make city elections non-partisan.From the Washington Times:

10/21/2009
Liberty Summit Officially Awesome
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Blog

Liberty Summit Officially Awesome

Senator Inhofe of Oklahoma helped kick off the Liberty Summit this morning over at the D.C. Armory.  Over 1500 people turned out for a great event.  Check out the video and pictures below. One caveat, I was running around all morning and didn't have a chance to take many pictures, but pictures from real photographers and a full report will be coming soon.

09/10/2009
"Meet Me In D.C." Video Contest Finalists
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Blog

"Meet Me In D.C." Video Contest Finalists

Thanks so much to everyone who sent in a video for the contest. We had a number of fantastic entries. Below are the four finalists in no particular order.Please check them out and leave comments about your favorite. We'll announce the winners tomorrow.Thanks again for your participation and don't forget to be in D.C on Saturday! 

09/08/2009
Pay-To-Play Would Hurt Job Growth
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Blog

Pay-To-Play Would Hurt Job Growth

Earlier this week, there was a great editorial in The Miami Herald by Glenn Garvin. Garvin argued that the pay-or-play provision (that “would require almost all businesses to either provide health insurance for their employees or pay a tax penalty of up to 8 percent of their payroll”) is a bad idea. He wrote that:

07/31/2009
Key Vote No: H.R. 3269
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Press Release

Key Vote No: H.R. 3269

To view a pdf version click here. On behalf of over 700,000 FreedomWorks members nationwide, I urge you to VOTE NO on H.R. 3269—the Corporate and Financial Institution Compensation Fairness Act sponsored by Rep. Barney Frank, D-MA.

07/31/2009
Oppose Restrictions to Biogeneric Drugs
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Press Release

Oppose Restrictions to Biogeneric Drugs

July 16, 2009Members of the 111th CongressU.S. House of RepresentativesWashington, D.C. 20515Dear Representative,FreedomWorks, a grassroots organization with more than 750,000 members nationwide, is actively engaged in the current debate over health care reform and has been a strong advocate of market-based reforms that would expand consumer choice and competition in the health care sector.  Independent of the larger debate over the direction of health care reform in America, however, I would like to alert you to a potentially dangerous amendment that is being offered to H.R. 3200, American’s Health Choices Act of 2009 by Rep. Eshoo that would severely restrict the emerging market for biogeneric drugs.With the rising cost of pharmaceutical drugs and healthcare, it is increasingly important to encourage competition in the market for life saving therapies.  Biologics show great promise and have been used to produce insulin, human growth hormone, and other important therapies.  Globally, the market for these drugs has increased to more than $60 billion.  To expand this market and increase access to these life-saving drugs, it is important that the Food and Drug Administration has a regulatory pathway to approve biogenerics, or biologic follow-ons.  Much like generics, biogenerics hold the promise of new competiton and expanded consumer choice in new therapies to treat a variety of conditions, from AIDS to Alzheimer’s, to several different cancers.Currently, the FDA has limited authority to approve biogenerics.  Many pharmaceutical companies claim that biologics are too complex to be produced as generics.  This is not true; there are a number of pharmaceutical companies—brand name and generic—that have the capability and desire to enter the market for biologics with expiring patents.  One biogeneric has already been approved by the FDA, and the agency has stated that it believes it is possible to establish an abbreviated approval process for these drugs that allows manufacturers to establish their bioequivalence.  Already, the European Union and Australia have established procedures to approve biogenerics.  As an important component of health care reform,  Congress should move forward with legislation to ensure all Americans enjoy access to the latest therapeutic drugs at the most affordable prices.  Unfortunately, the Eshoo Amendment includes a 12-year exclusivity period that will do little to promote the competition necessary to expand consumer choice and check rising health care costs. A market approach is the correct solution to getting less expensive therapies to patients, as it also encourages the development of new and desperately needed medicines.  For these reasons,  I urge you to vote “no” on the Eshoo Amendment.  FreedomWorks will continue to follow the health care reform debate closely, advocating market-based reforms that expand patient choice and improve access to life-saving therapies.Sincerely,Matt KibbePresident and CEO

07/16/2009

Pages